Corbus Pharmaceuticals Holdings, Inc.
NASDAQ:CRBPBiotechnology
+$0.14 today
- Market cap
- $50.18M
- Beta
- 2.59
- P/E (TTM)
- -1.3
- EPS (TTM)
- -$6.35
Volume 0.66M
Average 0.42M
Balance Sheet
Inspect the capital base behind the business.
Assets
$168.19M
FY 2025 · Annual
+7.9% YoYLiabilities
$20.69M
FY 2025 · Annual
+53.8% YoYEquity
$147.50M
FY 2025 · Annual
+3.6% YoYBalance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 25.01M | 17M | 13.72M | 17.2M | 28.49M |
| Short-term Investments | 72.64M | 42.19M | 7.18M | 131.86M | 134.78M |
| Net Receivables | 0 | 0 | 0 | 0 | 1.5M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 192.48K | 192.48K | 192K | 3.91M | 1.52M |
| Total Current Assets | 100.2M | 60.18M | 23.55M | 152.98M | 166.95M |
| Property, Plant & Equipment (Net) | 7M | 5.5M | 4.04M | 2.52M | 1.24M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 523.81K | 632.77K | 690K | 385K | 0 |
| Total Non-current Assets | 7.53M | 6.13M | 4.73M | 2.9M | 1.24M |
| Total Assets | 107.73M | 66.31M | 28.27M | 155.88M | 168.2M |
| Account Payables | 1.78M | 2.17M | 3.18M | 4.79M | 2.22M |
| Short-term Debt | 3.86M | 3.15M | 16.21M | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 133.71K | 36.87K | 39K | 2.28M | 2.86M |
| Total Current Liabilities | 17.01M | 12.64M | 31.89M | 11.82M | 20.69M |
| Long-term Debt | 15.64M | 15.98M | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 22.21K | 22.21K | 44K | 0 | 0 |
| Total Non-current Liabilities | 21.61M | 20.68M | 3.28M | 1.63M | 0 |
| Total Liabilities | 38.62M | 33.32M | 35.18M | 13.45M | 20.69M |
| Common Stock | 12.52K | 417 | 0 | 1K | 2K |
| Retained Earnings | (349.73M) | (392.08M) | (436.68M) | (476.89M) | (555.43M) |
| Accumulated OCI | (62.45K) | (126.09K) | (1K) | 35K | (53K) |
| Other Stockholders Equity | 0 | 0 | (0) | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 69.11M | 32.99M | (6.91M) | 142.43M | 147.5M |
| Total Debt | 26.59M | 25.09M | 20.89M | 3.24M | 1.63M |
| Net Debt | 1.58M | 8.09M | 7.16M | (13.96M) | (26.86M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $26.0M |
| Short-term Investments | $112.6M |
| Other Current | $5.0M |
| Total Current Assets | $143.6M |
| PP&E (Net) | $914.0K |
| Other Non-current | -$1 |
| Total Non-current Assets | $914.0K |
| Total Assets | $144.5M |
Analysis
Selected assets total $144.5M for Latest. The largest visible component is Short-term Investments at $112.6M, about 77.9% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| SC 13G | SC 13G filing | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 10, 2026 | |
| 8-K | Current report | Nov 10, 2026 | |
| 4 | Statement of changes in beneficial ownership | Nov 2, 2026 | |
| SC 13G/A | SC 13G/A filing | Nov 2, 2026 |
How much cash does CRBP have?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported $28.49M in cash and equivalents in fiscal 2025.
How much debt does CRBP carry?
Corbus Pharmaceuticals Holdings, Inc. (CRBP) reported $1.63M of total debt, with net debt of -$26.86M.
Continue the stock analysis
Jump to another research area for this company.